Rekha Hemrajani
Director/Board Member at MAXCYTE, INC.
Net worth: 127 614 $ as of 31/05/2024
Rekha Hemrajani active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Director/Board Member | 01/04/2020 | - |
| Independent Dir/Board Member | 01/04/2020 | - | |
| MAXCYTE, INC. | Director/Board Member | 15/06/2021 | - |
| Independent Dir/Board Member | 15/06/2021 | - | |
| Hemmo Pharma LLP | Director/Board Member | - | - |
| Corporate Officer/Principal | - | - | |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | Director/Board Member | 04/05/2020 | - |
Hemmo Pharmaceuticals Pvt Ltd.
 Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Piramal Pharma Ltd., Hemmo Pharmaceuticals Pvt Ltd. is an Indian company that develops and manufactures peptide APIs. The company is based in Mumbai, India. The CEO of the company is Madhu Vikram Utamsingh. Hemmo Pharmaceuticals was acquired by Piramal Pharma Ltd. on June 22, 2021 for $105.61 million. | Director/Board Member | - | - |
| Corporate Officer/Principal | - | - | |
BioAge Labs, Inc.
 BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | Director/Board Member | 19/08/2021 | - |
| Independent Dir/Board Member | 19/08/2021 | - |
Career history of Rekha Hemrajani
Former positions of Rekha Hemrajani
| Companies | Position | Start | End |
|---|---|---|---|
| JIYA ACQUISITION CORP. | Director/Board Member | 01/08/2020 | 01/11/2022 |
| Chief Executive Officer | 01/08/2020 | 01/11/2022 | |
| ADVERUM BIOTECHNOLOGIES, INC. | Director/Board Member | 01/05/2019 | 12/05/2021 |
| Independent Dir/Board Member | 01/05/2019 | 12/05/2021 | |
| ARAVIVE, INC. | Director/Board Member | 09/01/2020 | 08/04/2020 |
| Chief Executive Officer | 09/01/2020 | 08/04/2020 | |
| President | 09/01/2020 | 08/04/2020 | |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Rekha Hemrajani
| University of Michigan | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistics
International
| United States | 16 |
| India | 3 |
Operational
| Director/Board Member | 9 |
| Corporate Officer/Principal | 5 |
| Independent Dir/Board Member | 4 |
Sectoral
| Health Technology | 13 |
| Finance | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 8 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| MAXCYTE, INC. | Health Technology |
| SAGIMET BIOSCIENCES INC. | Health Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| RAPT THERAPEUTICS, INC. | Health Technology |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| ALX ONCOLOGY HOLDINGS INC. | Health Technology |
| Private companies | 7 |
|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Finance |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
BioAge Labs, Inc.
BioAge Labs, Inc. BiotechnologyHealth Technology BioAge Labs, Inc. develops biological products. It offers data with machine learning to measure human aging and accelerate drug discovery. The company was founded by Kristen Fortney and is headquartered in Berkeley, CA. | Health Technology |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Part of ALX Oncology Holdings, Inc., ALX Oncology, Inc. operates as a clinical-stage immuno-oncology company which develops therapies for cancers. The company is based in Burlingame, CA. The CEO of the company is Jaume Pons. | Health Technology |
Hemmo Pharmaceuticals Pvt Ltd.
Hemmo Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Piramal Pharma Ltd., Hemmo Pharmaceuticals Pvt Ltd. is an Indian company that develops and manufactures peptide APIs. The company is based in Mumbai, India. The CEO of the company is Madhu Vikram Utamsingh. Hemmo Pharmaceuticals was acquired by Piramal Pharma Ltd. on June 22, 2021 for $105.61 million. | Health Technology |
Jiya Acquisition Corp.
 Jiya Acquisition Corp. Financial ConglomeratesFinance Jiya Acquisition Corp. is a blank check company. The firm was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on identifying promising opportunities in the biopharmaceutical sector. The company was founded in August 2020 and is headquartered in Palo Alto, CA. | Finance |
| Hemmo Pharma LLP |
- Stock Market
- Insiders
- Rekha Hemrajani
- Experience
